These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 9356207)

  • 1. An explanation for failure to predict cyclosporine area under the curve using a limited sampling strategy: a beginner's second note.
    Wu G
    Pharmacol Res; 1997 Jun; 35(6):547-52. PubMed ID: 9356207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of area under the whole blood concentration versus time curve after first intravenous cyclosporine dose in children undergoing hematopoietic stem cell transplant: limited sampling strategies.
    Sibbald C; Seto W; Taylor T; Saunders EF; Doyle J; Dupuis LL
    Ther Drug Monit; 2008 Aug; 30(4):434-8. PubMed ID: 18641547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction of area under the cyclosporine concentration versus time curve in children undergoing hematopoietic stem cell transplantation.
    Dupuis LL; Seto W; Teuffel O; Gibson P; Schultz KR; Doyle JD; Gassas A; Egeler RM; Sung L; Schechter T
    Biol Blood Marrow Transplant; 2013 Mar; 19(3):418-23. PubMed ID: 23128321
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A limited sampling strategy for the estimation of 12-hour cyclosporine neoral area under the curve in Chinese cardiac transplant recipients.
    Wang CH; Ko WJ; Chou NK; Wang SS
    Transplant Proc; 2004 Oct; 36(8):2390-2. PubMed ID: 15561259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of limited sampling strategies for estimation of cyclosporine area under the concentration-time curve in hematopoietic stem cell transplant patients.
    Hadjibabaie M; Vazirian I; Iravani M; Moosavi SA; Alimoghaddam K; Ghavamzadeh A; Rezaee S
    Ther Drug Monit; 2011 Dec; 33(6):673-80. PubMed ID: 22011723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic drug monitoring of cyclosporine Neoral in de novo Chinese cardiac transplant recipients treated with an everolimus-cyclosporine immunosuppressive regimen.
    Wang CH; Chou NK; Wu FL; Ko WJ; Tsao CI; Chi NH; Hsu RB; Wang SS
    Transplant Proc; 2006 Sep; 38(7):2132-4. PubMed ID: 16980022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Limited sampling strategy for cyclosporine (Neoral) area under the curve monitoring in pediatric kidney transplant recipients.
    Strong DK; Lai A; Primmett D; White CT; Lirenman DS; Carter JE; Hurley RM; Virji M; Ensom MH
    Pediatr Transplant; 2005 Oct; 9(5):566-73. PubMed ID: 16176411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of sparse sampling strategies to estimate cyclosporine A area under the concentration-time curve using either a specific radioimmunoassay or high-performance liquid chromatography method.
    Koristkova B; Grundmann M; Brozmanova H; Perinova I; Safarcik K
    Ther Drug Monit; 2010 Oct; 32(5):586-93. PubMed ID: 20683391
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal assessment of everolimus in de novo renal transplant recipients over the first post-transplant year: pharmacokinetics, exposure-response relationships, and influence on cyclosporine.
    Kovarik JM; Kahan BD; Kaplan B; Lorber M; Winkler M; Rouilly M; Gerbeau C; Cambon N; Boger R; Rordorf C;
    Clin Pharmacol Ther; 2001 Jan; 69(1):48-56. PubMed ID: 11180038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Easy-to-use, accurate and flexible individualized Bayesian limited sampling method without fixed time points for ciclosporin monitoring after liver transplantation.
    Langers P; Cremers SC; den Hartigh J; Rijnbeek EM; Ringers J; Lamers CB; van Hoek B
    Aliment Pharmacol Ther; 2005 Mar; 21(5):549-57. PubMed ID: 15740538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of oral cyclosporine (Neoral) in heart transplant recipients during the immediate period after surgery.
    Banner NR; David OJ; Leaver N; Davis J; Breen J; Johnston A; Yacoub MH
    Transpl Int; 2002 Dec; 15(12):649-54. PubMed ID: 12478413
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A limited sampling strategy for the estimation of Neoral AUCs in pediatric patients.
    Meier-Kriesche HU; Bonilla-Felix MA; Ferris ME; Swinford R; Kahan BD; Brannan P; Portman RJ
    Pediatr Nephrol; 1999 Nov; 13(9):742-7. PubMed ID: 10603112
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A comparison of measured trough levels and abbreviated AUC estimation by limited sampling strategies for monitoring mycophenolic acid exposure in stable heart transplant patients receiving cyclosporin A-containing and cyclosporin A-free immunosuppressive regimens.
    Dösch AO; Ehlermann P; Koch A; Remppis A; Katus HA; Dengler TJ
    Clin Ther; 2006 Jun; 28(6):893-905. PubMed ID: 16860172
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a predictive limited sampling strategy for estimation of mycophenolic acid area under the concentration time curve in patients receiving concomitant sirolimus or cyclosporine.
    Figurski MJ; Nawrocki A; Pescovitz MD; Bouw R; Shaw LM
    Ther Drug Monit; 2008 Aug; 30(4):445-55. PubMed ID: 18641543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-dose and steady state pharmacokinetics of CSA and two main primary metabolites, AM1 and AM4n in patients with rheumatic/autoimmune diseases.
    Suchy D; Dostalek M; Perinova I; Brozmanova H; Grundmann M; Vyskocil V; Mayer O
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2011 Sep; 155(3):269-74. PubMed ID: 22286813
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine.
    Capone D; Tarantino G; Kadilli I; Polichetti G; Basile V; Federico S; Sabbatini M
    Nephrol Dial Transplant; 2011 Sep; 26(9):3019-25. PubMed ID: 21317409
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A possible simplification for the estimation of area under the curve (AUC₀₋₁₂) of enteric-coated mycophenolate sodium in renal transplant patients receiving tacrolimus.
    Fleming DH; Mathew BS; Prasanna S; Annapandian VM; John GT
    Ther Drug Monit; 2011 Apr; 33(2):165-70. PubMed ID: 21383656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The possibility of using the specific RIA method for the area-under-time-concentration curve sparse sampling calculation of cyclosporin A despite a large post-dose overestimation.
    Grundmann M; Koristkova B; Brozmanova H; Perinova I; Safarcik K
    Int J Clin Pharmacol Ther; 2011 Jan; 49(1):30-7. PubMed ID: 21176722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic drug monitoring of cyclosporine.
    Jorga A; Holt DW; Johnston A
    Transplant Proc; 2004 Mar; 36(2 Suppl):396S-403S. PubMed ID: 15041374
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetics of cyclosporine in recipients of marginal versus standard liver transplants.
    Casale F; Lupo F; Passera R; Liddo G; Moscato D; Mosso R; Zara GP; Eandi M; Salizzoni M
    Pharmacol Res; 2006 Oct; 54(4):287-92. PubMed ID: 16884914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.